House r6953 Status Act

Therapeutic Goods Amendment (2022 Measures No. 1) Bill 2022

47th Parliament Government Portfolio: Health and Aged Care

Amends the Therapeutic Goods Act 1989 to:

  • require mandatory reporting of adverse events involving medical devices
  • provide a marketing approval pathway for biologicals that are for export only
  • remove merits review rights for a decision by the secretary to require a person to provide information or documents under the Act
  • enable the secretary to extend the period for a person to pay the amount stated in an infringement notice, and require a person to provide information or documents that are relevant to a contravention of the Act
  • extend the period for which seized goods can be held
  • provide that therapeutic goods advertising is excluded from advertising restrictions for certain health professionals or to persons purchasing goods on behalf of governments, registered charities or health facilities
  • enable the secretary to withdraw approval for the use of a restricted representation in an advertisement about therapeutic goods
  • enable the secretary to approve the importation or supply of substitute overseas prescription medicine that has been previously approved within Australia
  • provide that the secretary is not required to observe any requirements of the natural justice hearing rule when releasing therapeutic goods information
  • provide that sponsors of reportable medicines that are in shortage must provide updated information to the secretary
  • make technical amendments.

Summary from the official bill homepage.

Documents

Official record: bill homepage at aph.gov.au, full text and documents on ParlInfo.